Kinuya Seigo, Yoneyama Tatsuya, Michigishi Takatoshi
Department of Biotracer Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takaramachi, Kanazawa 920-8640, Japan.
Ann Nucl Med. 2007 Aug;21(6):367-9. doi: 10.1007/s12149-007-0034-y. Epub 2007 Aug 27.
Airway complications rarely occur in 131I radioiodine therapy for Graves' disease. This study presents two cases in which 131I therapy caused this acute complication. The patients complained of the symptom 6 h and 33 h after administration of 131I. A histamine H1 receptor antagonist and hydrocortisone rapidly resolved symptoms in both cases. These two cases remind physicians that 131I therapy for Graves' disease may cause potentially life-threatening complications.
在格雷夫斯病的¹³¹I放射性碘治疗中，气道并发症很少发生。本研究介绍了两例¹³¹I治疗引发这种急性并发症的病例。患者在服用¹³¹I后6小时和33小时出现症状。在这两例中，组胺H1受体拮抗剂和氢化可的松迅速缓解了症状。这两例病例提醒医生，格雷夫斯病的¹³¹I治疗可能会引发危及生命的并发症。
